Literature DB >> 20452314

A call to standardize teratoma assays used to define human pluripotent cell lines.

Franz-Josef Müller1, Johanna Goldmann, Peter Löser, Jeanne F Loring.   

Abstract

The teratoma assay is the gold standard for documenting pluripotency of human stem cells. However, reports of new human ESC and iPSC lines vary widely in both methods and analysis of teratoma data. We call for consensus standards to be established to make this assay worthy of its "golden" status.

Entities:  

Mesh：

Year:  2010        PMID： 20452314     DOI： 10.1016/j.stem.2010.04.009

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  62 in total

1.  A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells.

Authors:  Rebekah L Gundry; Daniel R Riordon; Yelena Tarasova; Sandra Chuppa; Subarna Bhattacharya; Ondrej Juhasz; Olena Wiedemeier; Samuel Milanovich; Fallon K Noto; Irina Tchernyshyov; Kimberly Raginski; Damaris Bausch-Fluck; Hyun-Jin Tae; Shannon Marshall; Stephen A Duncan; Bernd Wollscheid; Robert P Wersto; Sridhar Rao; Jennifer E Van Eyk; Kenneth R Boheler
Journal:  Mol Cell Proteomics       Date:  2012-04-06       Impact factor: 5.911

2.  Putting stem cells to the test.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2010-12       Impact factor: 53.440

3.  Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.

Authors:  Jaroslav Slamecka; Lilia Salimova; Steven McClellan; Mathieu van Kelle; Debora Kehl; Javier Laurini; Paolo Cinelli; Laurie Owen; Simon P Hoerstrup; Benedikt Weber
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 4.  The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues.

Authors:  Malwina Suszynska; Ewa K Zuba-Surma; Magdalena Maj; Kasia Mierzejewska; Janina Ratajczak; Magda Kucia; Mariusz Z Ratajczak
Journal:  Stem Cells Dev       Date:  2014-01-11       Impact factor: 3.272

Review 5.  Inducing iPSCs to escape the dish.

Authors:  Bonnie Barrilleaux; Paul S Knoepfler
Journal:  Cell Stem Cell       Date:  2011-08-05       Impact factor: 24.633

6.  Teratoma formation: a tool for monitoring pluripotency in stem cell research.

Authors:  Raman V Nelakanti; Nigel G Kooreman; Joseph C Wu
Journal:  Curr Protoc Stem Cell Biol       Date:  2015-02-02

7.  Association of telomere length with authentic pluripotency of ES/iPS cells.

Authors:  Junjiu Huang; Fang Wang; Maja Okuka; Na Liu; Guangzhen Ji; Xiaoying Ye; Bingfeng Zuo; Minshu Li; Ping Liang; William W Ge; John Cm Tsibris; David L Keefe; Lin Liu
Journal:  Cell Res       Date:  2011-02-01       Impact factor: 25.617

Review 8.  Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.

Authors:  Joanna S T Asprer; Uma Lakshmipathy
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 9.  The decision on the "optimal" human pluripotent stem cell.

Authors:  Margit Rosner; Katharina Schipany; Markus Hengstschläger
Journal:  Stem Cells Transl Med       Date:  2014-04-01       Impact factor: 6.940

10.  Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection.

Authors:  Ivan Gutierrez-Aranda; Veronica Ramos-Mejia; Clara Bueno; Martin Munoz-Lopez; Pedro J Real; Angela Mácia; Laura Sanchez; Gertrudis Ligero; Jose L Garcia-Parez; Pablo Menendez
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.